Home Site Map Contact Us
  Back to Salix Products
XIFAXAN

Reimbursement Information

  • XIFAXAN Home
  • About XIFAXAN
  • Safety & Side Effects
  • What Is “Gut Flora?”
  • FAQs
  • Travelers’ Diarrhea
  • Patient Education Brochure
  • Travel Tips
  • Reimbursement Information

3-Step XIFAXAN Reimbursement


Step 1: Fill Out The Form

Download the Patient Information Form and fill it out.

 Patient Information Form (PDF 19KB)

 Patient Information Form (MS-Word)

For easy-to-follow instructions and an example of a filled-out Patient Information Form, click below to view our brochure, "Completing the Patient Information Form."

 Completing the Patient Information Form (PDF 254KB)


Step 2: Get Questions Answered

This free support service connects trained reimbursement analysts with XIFAXAN® customers to answer questions regarding the Patient Information Form and to provide reimbursement support. Our staff can also negotiate appeals on behalf of your patients, should their claims be denied

XIFAXAN Reimbursement Helpline - 1-866-943-2926

XIFAXAN Reimbursement Helpline
1-866-XIFAXAN
1-866-943-2926

Open Monday through Friday, 8:30 AM to 5:30 PM Eastern Standard Time

What should you have before calling?
To make the most efficient use of your time, complete the Patient Information Form (PDF 19KB) before calling and have it with you.


Step 3: Submit Completed Form

Completed claim forms must be submitted via this fax number.

XIFAXAN Reimbursement Fax Line - 1-800-387-5807

XIFAXAN Reimbursement Fax Line
1-800-387-5807


Reasons to contact the XIFAXAN Reimbursement Helpline

The XIFAXAN Reimbursement Helpline can provide a timely solution to issues you may encounter either before or after submitting a patient claim for reimbursement.

  • Receive current reimbursement policies for private payers, Medicaid, and Medicare
  • Verify individual patient coverage
  • Verify insurance coverage associated with the patient assistance program
  • Conduct prior authorizations
  • Manage negotiation of appeals on denied claims
  • Receive customized information to assist with coverage or appeals

Get Adobe Acrobat Reader

Get Acrobat Reader

SAFETY CONSIDERATIONS

Xifaxan® (rifaximin) Tablets are indicated for the treatment of patients (≥12 years of age) with travelers’ diarrhea caused by noninvasive strains of Escherichia coli. Xifaxan should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than Escherichia coli. Xifaxan should be discontinued if diarrhea symptoms get worse or persist more than 24-48 hours and alternative antibiotic therapy should be considered. Escherichia coli has been shown to develop resistance to rifaximin in vitro. However, the clinical significance of such an effect has not been studied.

In clinical trials, Xifaxan was generally well tolerated. The most common side effects (vs. placebo) were flatulence 11.3% (vs. 19.7%), headache 9.7% (vs. 9.2%), abdominal pain 7.2% (vs. 10.1%), rectal tenesmus 7.2% (vs. 8.8%), defecation urgency 5.9% (vs. 9.2%) and nausea 5.3% (vs. 8.3%).

For complete Prescribing Information, please click here.


For product information, adverse event reports, and product complaint reports please call:

Salix Product Information Call Center
Phone: 1-800-508-0024
Fax: 1-510-595-8183
Email:

  • Travelers' Diarrhea Fact Pack

  • XIFAXAN Physician Resource Center

  • XIFAXAN Product Prescribing Information

Click here for Patient Brochure.